Realistic Approach To AI In Drug Discovery

Omar Gadir, Ph. D., Founder/CEO. AI Hype And Reality. Artificial intelligence, Deep Learning, Machine Learning and cognitive computing are the

Effective Analytics Model For Pharma R&D

Omar Gadir, Ph. D., Founder/CEO. Introduction Some pharma companies started investing in data analytics trying to overcome their R&D crisis.

Empowering Pharma Domain Experts To Perform Data Analytics

Omar Gadir, Ph. D., Founder/CEO. Introduction Despite impressive innovations in pharmaceutical technologies, companies are not producing drugs any faster than

Software Solution To Pharma R&D Crisis

Omar Gadir, Ph. D., Founder/CEO. Pharma R&D Crisis The pharma industry has entered a severe crisis. There has been a

Machine Learning: The Wide Gap Between Hype And Reality

Omar Gadir, Ph. D., Founder/CEO. Machine learning has great potential, but it is not a silver bullet. It cannot provide

Iteru’s Solution To The Democratization Of Data

Omar Gadir, Ph. D., Founder/CEO. Most of the new data analysis products put the burden of extracting insights from data

Using Machine Learning Tools

Omar Gadir, Ph. D., Founder/CEO. Iteru’s provides an end-to-end product for data analysis. It has been designed such that it

All Data Is Important, Whether It is Machine-made Or Man-made

Omar Gadir, Ph. D., Founder/CEO. Source Of Unstructured Data. Unstructured data could be generated by machines (machine-made data) or by humans

AI For Cancer Drug Discovery

Omar Gadir, Ph. D., Founder/CEO. Stages Of Drug Discovery. Fig. 1 AI shortens and reduces the cost of drug discovery.